A Double-Blind, Placebo-Controlled Trial of Ruxolitinib for Myelofibrosis
2012 · New England Journal of Medicine · 2,004 citations
https://doi.org/10.1056/nejmoa1110557
A
Azra Raza
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
439
Papers
20.5K
Citations
63
h-index
201
i10-index
Azra Raza is an academic researcher from Columbia University Irving Medical Center. The author has contributed to research in topics: Acute Myeloid Leukemia Research & Myeloproliferative Neoplasms: Diagnosis and Treatment & Chronic Myeloid Leukemia Treatments. The author has an h-index of 63, co-authored 374 publications.
ORCID: 0000-0002-9734-5210Papers by this author
worksA deep catalogue of protein-coding variation in 983,578 individuals
2024 · Nature · 93 citations
https://doi.org/10.1038/s41586-024-07556-0
Phase 1-2a multicenter dose-escalation study of ezatiostat hydrochloride liposomes for injection (Telintra®, TLK199), a novel glutathione analog prodrug in patients with myelodysplastic syndrome
2009 · Journal of Hematology & Oncology · 62 citations
https://doi.org/10.1186/1756-8722-2-20
Phase 1 dose-ranging study of ezatiostat hydrochloride in combination with lenalidomide in patients with non-deletion (5q) low to intermediate-1 risk myelodysplastic syndrome (MDS)
2012 · Journal of Hematology & Oncology · 27 citations
https://doi.org/10.1186/1756-8722-5-18
Circulating cancer giant cells with unique characteristics frequently found in patients with myelodysplastic syndromes (MDS)
2023 · Medical Oncology · 9 citations
https://doi.org/10.1007/s12032-023-02064-z
A niche driven mechanism determines response and a mutation-independent therapeutic approach for myeloid malignancies
2025 · Cancer Cell · 3 citations
https://doi.org/10.1016/j.ccell.2025.03.007
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat